Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence
- PMID: 32418181
- PMCID: PMC7229438
- DOI: 10.1007/s10840-020-00765-3
Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence
Abstract
COVID-19 infection has shown rapid growth worldwide, and different therapies have been proposed for treatment, in particular, the combination of immune response modulating drugs such as chloroquine and hydroxychloroquine (antimalarials) alone or in combination with azithromycin. Although the clinical evidence supporting their use is scarce, the off label use of these drugs has spread very quickly in face of the progression of the epidemic and the high mortality rate in susceptible populations. However, these medications can pathologically prolong the QT interval and lead to malignant ventricular arrhythmias such that organized guidance on QT evaluation and management strategies are important to reduce morbidity associated with the potential large-scale use.
Keywords: Azithromycin; COVID 19; Chloroquine; Hydroxychloroquine; QT interval; Torsade de pointes.
Figures
Similar articles
-
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin.J Interv Card Electrophysiol. 2020 Nov;59(2):337-345. doi: 10.1007/s10840-020-00822-x. Epub 2020 Jul 11. J Interv Card Electrophysiol. 2020. PMID: 32654098 Free PMC article.
-
Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection.Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008662. doi: 10.1161/CIRCEP.120.008662. Epub 2020 Apr 29. Circ Arrhythm Electrophysiol. 2020. PMID: 32347743 Free PMC article.
-
QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor.Eur J Clin Invest. 2020 Nov;50(11):e13407. doi: 10.1111/eci.13407. Epub 2020 Sep 25. Eur J Clin Invest. 2020. PMID: 32918829 No abstract available.
-
Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol.Eur Heart J Acute Cardiovasc Care. 2020 Apr;9(3):215-221. doi: 10.1177/2048872620922784. Epub 2020 May 6. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 32372695 Free PMC article. Review.
-
Saudi Heart Rhythm Society Task Force on Management of Potential Arrhythmogenicity Associated with Pharmacotherapy for COVID-19.Ann Saudi Med. 2020 Sep-Oct;40(5):365-372. doi: 10.5144/0256-4947.2020.365. Epub 2020 Oct 1. Ann Saudi Med. 2020. PMID: 32954790 Free PMC article. Review.
Cited by
-
Prevalence and predictors of false positive QTc prolongation by the automated measurement.Front Cardiovasc Med. 2024 Oct 10;11:1465264. doi: 10.3389/fcvm.2024.1465264. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39450233 Free PMC article.
-
Pathophysiological effects of SARS-CoV-2 infection on the cardiovascular system and its clinical manifestations-a mini review.Front Cardiovasc Med. 2023 May 16;10:1162837. doi: 10.3389/fcvm.2023.1162837. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37260945 Free PMC article. Review.
-
CT Imaging Features and Clinical Characteristics of 2019 Novel Coronavirus Pneumonia (COVID-19) During Rehabilitation.Iran J Sci Technol Trans A Sci. 2022;46(4):1171-1176. doi: 10.1007/s40995-022-01338-x. Epub 2022 Aug 8. Iran J Sci Technol Trans A Sci. 2022. PMID: 35967904 Free PMC article.
-
A Narrative Review of Existing Options for COVID-19-Specific Treatments.Adv Virol. 2021 Nov 12;2021:8554192. doi: 10.1155/2021/8554192. eCollection 2021. Adv Virol. 2021. PMID: 34804163 Free PMC article. Review.
-
Heart Muscle Microphysiological System for Cardiac Liability Prediction of Repurposed COVID-19 Therapeutics.Front Pharmacol. 2021 Aug 4;12:684252. doi: 10.3389/fphar.2021.684252. eCollection 2021. Front Pharmacol. 2021. PMID: 34421592 Free PMC article.
References
-
- Hocht C, Opezzo J, Taira C. Intervalo QT prolongado inducido por fármacos desde el punto de vista de un farmacólogo. Rev Arg Cardiol. 2004;72(6):474–480.
-
- Woosley R. Cardiac complications of chloroquine based therapy. Cardiology. 2020. https://www.practiceupdate.com/content/cardiac-complications-of-chloroqu....
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

